Journals / The Anatolian Journal of Cardiology / 2015 / Cilt: 15 - Sayı: 1

The role of isovolumic acceleration in predicting subclinical right and left ventricular systolic dysfunction in patient with metabolic syndrome

Pages
42–49
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This disruption lead to decreased function of heart was related with raised risk factors of MetS. (Anatolian J Cardiol 2015; 15: 42-9

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of this study was to assess subclinical left (LV) and right ventricular (RV) dysfunction novel load-independent isovolumic myocardial acceleration (IVA) derived from tissue Doppler imaging (TDI) in patient with metabolic syndrome (MetS).Methods: This study had an observational case-control design.
📊
Key Findings & Data:The study included 133 subjects which were divided into two groups: 75 patients with MetS and 58 controls without MetS.
💡
Conclusion & Impact:This disruption lead to decreased function of heart was related with raised risk factors of MetS. (Anatolian J Cardiol 2015; 15: 42-9
🔬Design:Research Article
📍Scope:2015 Verileri
⚙️Variables:Domain Parameters

Özet

Objective: The aim of this study was to assess subclinical left (LV) and right ventricular (RV) dysfunction novel load-independent isovolumic myocardial acceleration (IVA) derived from tissue Doppler imaging (TDI) in patient with metabolic syndrome (MetS).Methods: This study had an observational case-control design. The study included 133 subjects which were divided into two groups: 75 patients with MetS and 58 controls without MetS. MetS was defined by the presence of ≥3 criteria according to ATP-NCEP III guidelines. All the subjects underwent laboratory blood tests and complete conventional echocardiography and TDI. Student’s t, Mann-Whitney U, Pearson's, and multiple regression analysis were used for statistical analysis.Results: There were no significant difference between two groups in terms of traditional echocardiographic parameters. The diastolic and global functions of both ventricles were significantly impaired in MetS group. The TDI-derived IVA of the LV and the RV was significantly lower in patients with MetS (3.2±0.9 vs. 4.0±1.4, p<0.001 and 2.6±0.7 vs. 3.1±0.9, p=0.001, respectively). Whereas, TDI derived systolic velocity (Sa), and peak myocar-dial velocity during isovolumic contraction (IVV) of both ventricles were similar between the two groups. In the multiple regression analysis, waist circumference and diastolic blood pressure were found to be an independent determinant of IVA of LV (β=-.223, 95% CI=-.034 -.002, p=0.004) and RV (β=-.527, 95% CI=-.085 -.020, p=0.002) respectively.Conclusion: MetS affects global, diastolic, and systolic functions of two ventricles. This disruption lead to decreased function of heart was related with raised risk factors of MetS. (Anatolian J Cardiol 2015; 15: 42-9

🔖

Cite This Article

ERTÜRK, M., ÖNER, E., KALKAN, A. K., PÜŞÜROĞLU, H., ÖZYILMAZ, S. Ö., AKGÜL, Ö., ÜNAL, H. A., AKTÜRK, İ. F., ÇELİK, Ö., USLU, N. (2015). The role of isovolumic acceleration in predicting subclinical right and left ventricular systolic dysfunction in patient with metabolic syndrome. The Anatolian Journal of Cardiology, Cilt: 15 - Sayı: 1, 42–49. https://ajindex.com/articles/365893

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet
  2. [CrossRef] LV IVA 2. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. American Heart Association
  3. National Heart, Lung and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005
  4. [CrossRef] 3. Chinali M, Devereux RB, Howard BV, Roman MJ, Bella JN, Liu JE, et al. Comparison of cardiac structure and function in American Indians with and without the metabolic syndrome (the Strong Heart Study). Am J Cardiol 2004
  5. [CrossRef] 4. Ivanovic B, Tadic M, Simic D. Are all criteria of metabolic syndrome equally harmful? Acta Cardiol 2011
  6. Tadic M, Ivanovic B, Grozdic I. Metabolic syndrome impacts the right ventricle: true or false? Echocardiography 2011
  7. [CrossRef] 6. Karakurt Ö, Öztekin S, Yazıhan N, Akdemir R. Impaired right ventricular functions in metabolic syndrome patients with preserved left ventricular ejection fraction. Arch Turk Soc Cardiol 2011
  8. [CrossRef] 7. Vogel M, Cheung MM, Li J, Kristiansen SB, Scmidt MR, White PA, et al. Noninvasive assessment of left ventricular force-frequency relationships using tissue Doppler derived isovolumetric acceleration: validation in an animal model. Circulation 2003
  9. [CrossRef] 8. Vogel M, Schmidt MR, Kristiansen SB, Cheung M, White PA, Sorensen K, et al. Validation of myocardial acceleration during isovolumic contraction as a novel noninvasive index of right ventricular contractility: comparison with ventricular pressure-volume relations in an animal model. Circulation 2002
  10. [CrossRef] 9. Toyono M, Harada K, Tamura M, Yamamoto F, Takada G. Myocardial acceleration during isovolumic contraction as a new index of right ventricular contractile function and it's relation to pulmonary regurgitation in patients after repair of tetrology of Fallot. J Am Soc Echocardiogr 2004
  11. [CrossRef] 10. Ertürk M, Aksu HU, Çelik O, Uzun F, Akgül O, Pusuroğlu H, et al. Evaluation of the effect of mitral stenosis severity on the left ventricular systolic function using isovolumic myocardial acceleration. Cardiol J 2013 Nov 6. [Epub ahead of print]. [CrossRef] 11. Who Guideline Development Committee. Defination and diagnosis of diabetes mellitus and intermediate hyperglisemia. Report of a WHO/IDF Consultation, Geneve 2006